Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Padcev
Pharma
Pfizer cranks up revenue outlook amid Paxlovid sales bump
The company is projecting yearly sales of $61 billion to $64 billion in a $1.5 billion boost from previous forecasts.
Zoey Becker
Oct 29, 2024 10:40am
UPDATED: Astellas employee indicted by China’s prosecutors
Aug 21, 2024 11:10am
Pfizer sees 8 blockbuster cancer drugs from each focus area
Jun 13, 2024 12:45pm
BMS, overshadowed by ADC rival, wins FDA nod in 1L bladder cancer
Mar 8, 2024 9:56am
Leqembi, Takeda, Roche—Fierce Pharma Asia
Feb 9, 2024 9:02am
Astellas raises expectations for Padcev, lowers them for Veozah
Feb 5, 2024 10:57am
